HIGH QUALITY SERVICE

high technology innovation , high speed development.

HIGH QUALITY SERVICE

上海芯超生物科技有限公司 
生物芯片上海国家工程研究中心

上海市高新技術企業

  • 上海芯超生物科技有限公司成立於2003年12月18日
  • 為美國BIOXXX 組織晶片公司之上游供應商

擁有十五863消化道腫瘤組織庫與組織芯片重大項目、十一五863胰腺癌基因組重大項目、衛生部肝癌組織芯片分子標記物篩選重大項目、863胃癌易感基因與幽門螺桿菌耐藥基因聯合檢測重點項目。

商品介紹

Catalog

Diameter

Dots

Cases

Description

HKidC080PT01

(kidney)

1.5mm

80

40

40 cases of renal cell carcinoma, clear cell cancer, papillary cell carcinoma, chromophobe cell carcinoma, real cystic renal cell carcinoma, Bellini collection duct carcinoma, nephroblastoma, mucinous tubular and spindle cell carcinoma.

HKid-CRC030PG-01

(kidney)

2.0mm

30

15

1. kidney clear cell carcinoma (15 cases),  Tumor (2 cores/case) and matched normal adjacent tissue (2 cores/case).
2. Pathology grade 2

HKid-CRC060CS-01

(kidney)

2.0mm

60

30

1.25 cases Renal clear cell carcinoma, tumor with matched normal adjacent tissue(or  remote tissue/NAT/tumor)
2.Clinical stage(AJCC 7.0)I  II  III  IV
3.5 cases of kidney cancer metastases

HKid-CRC180Sur-01

(kidney)

1.5mm

180

90

1. Kidney clear cell carcinoma (90 cases), tumor (1 core/case) and matched normal adjacent tissue (1 core/case).
2. Survival information available. Being followed up for 5.5 - 7 years.

HKid-CRCC060PG-01

(kidney)

2.0mm

60

30

1. Kidney clear cell carcinoma (30 cases), tumor (1 core/case) and matched normal adjacent tissue (1 core/case). 
2. Pathology grade 1 ( 1 case),  1-2(2 cases), 2 (22 cases), 3 (5 cases).

HKid-CRCC150CS-01

(kidney)

1.5mm

150

75

1. Kidney clear cell carcinoma (75 cases), tumor (1 core/case) and matched normal adjacent tissue (1 core/case)   
2. 
Clinical stage I (33 cases), II ( 24 cases), III (17 cases), IV (1 case).  
3. 
100% cases have TNM detail information.
4. Pathology grade 1, 2, 3.
5. 43 cases have survival information.

HKid-CRCC150CS-02

(kidney)

1.5mm

150

75

1. Kidney clear cell carcinoma (75 cases), tumor (1 core/case) and matched normal adjacent tissue (1 core/case)  
2. Clinical stage I (29 cases), II ( 23 cases), III (17 cases), IV (6 case). 
3. 100% cases have TNM detail information.
4. Pathology grade 1, 2, 3.

HKidE030PG02

(kidney)

2.0mm

60

30

clear cell renal  carcinoma 30 cases: 1 core/case, grade I-Ⅲ.

HKidE180Su02

(kidney)

1.5mm

180

150

1. Kidney clear cell carcinoma (150 cases), 150 cases of tumor (1 core/case) and 30 cases of matched normal adjacent tissue (1 core/case).
2Survival information available. Being followed up for 5.5 - 7.5 years. visit date 2015.08

OD-CT-UrKid01-004

(kidney)

1.0mm

248

62

1.  Kidney clear cell carcinoma (62 cases). 
2.  Tumor (2 cores/case) and matched normal adjacent tissue (2 cores/case).

OD-CT-UrKid01-005

(kidney)

1.0mm

248

62

1. Kidney carcinoma (62 cases), containing kidney clear cell carcinoma (34 cases), papillary renal cell carcinoma (20 cases), chromophobe cell carcinoma (7 cases) and oncocytoma (1 case).
2. Tumor (2 cores/case) and matched normal adjacent tissue (2 cores/case).

OD-CT-UrKid02-001

(kidney)

2.0mm

32

32

1. Kidney clear cell carcinoma (32 cases), 1 core/case. 
2. Pathology grade 1.

OD-CT-UrKid03-001

(kidney)

2.0mm

62

62

1. Kidney clear cell carcinoma (62 cases), 1 core/case. 
2. Pathology grade 1, 1-2, 2.

OD-CT-UrKid03-002

(kidney)

2.0mm

62

31

1. Kidney clear cell carcinoma (31 cases), tumor (1 core/case) and matched normal adjacent tissue (1 core/case). 
2. Pathology grade 1.

OD-CT-UrKid03-003

(kidney)

2.0mm

62

31

1. Kidney carcinoma (31 cases), containing kidney clear cell carcinoma (10 cases), papillary renal cell carcinoma (11 cases), chromophobe cell carcinoma (9 cases). Tumor (1 core/case) and matched normal adjacent tissue (1 core/case).  
2. 
Clinical stage I, II, III (Version 7.0).  
3. 
100% cases have TNM detail information. 
4. 
Pathology grade 1, 2, 3.

OD-CT-UrKid04-001

(kidney)

1.5mm

85

40

1. Kidney clear cell carcinoma (40 cases), 2 cores/case. Normal adjacent tissue (5 cases), 1 core/case. 
2. Clinical stage I, II, III (Version 7.0).  
3. 
Pathology Grade 1, 2, 3.

HRaU-Uro120Sur-01

(kidney pelvis and ureter)

1.5mm

120

120

1. Kidney pelivis carcinoma and ureter carcinoma, 120cases. Tumor, 1 core/case  
2. Survival information available. Being followed up for 0.5-7 years.